Acucela DRC A Phase 2a Multicenter, Randomized, Masked Study Evaluating the Pharmacodynamics of Emixustat Hydrochloride in Subjects with Macular Atrophy Secondary to Stargardt Disease

Administered By

Awarded By

Contributors

Start/End

  • December 6, 2016 - May 9, 2018